Mandatory notification of trade

Bergen, Norway 3 November 2023: Reference is made to stock exchange notification 1 June 2022 with notification of trade of 25 000 shares by primary insider Joacim Holter. Enclosed to the stock exchange notification was a KRT 1500 form informing that the shares was planned to be transferred to Joacim Holters children. Today, Lifecare has received notification that Joacim Holter accordingly has transferred a total of 24 999 shares to his closely related parties; * Ingrid Holter (8 333 shares), * Julie Holter, (8 333 shares), * Fredrik Holter, (8 333 shares), for a price of 3,00 NOK per share. After the transfer, Joacim Holter holds a total of 292 998 shares in Lifecare AS, as well as 1 331 355 shares through his fully owned investment company Cimter AS, 1 331 355 shares. About us Lifecare AS is a clinical stage medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's main focus is to bring the next generation of Continuous Glucose Monitoring ("CGM") systems to market. Lifecare enables osmotic pressure as sensing principle, combined with the ability to manipulate Nano-granular Tunnelling Resistive sensors ("NTR") on the sensor body for read-out of pressure variations. Lifecare's sensor technology is referred to as "Sencell" and is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body. Contacts For further information, please contact: Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40 Asle Wingsternes, Head of Communications & Public Affairs, asle.wingsternes@lifecare.no, +47 41 61 42 52 This information is information that Lifecare AS is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-11-03 18:15 CET.